Toradol vs Tramadol: How NSAIDs and Opioids Differ

Toradol (ketorolac) and tramadol belong to entirely different drug classes, even though their names sound almost interchangeable. Toradol is a nonsteroidal anti-inflammatory drug, while tramadol is an opioid-like painkiller that also affects brain chemistry related to mood. That distinction shapes everything about how they work, which side effects they carry, who should avoid them, and when one makes more sense than the other.

How They Work in Your Body

Ketorolac, the generic name behind the brand Toradol, works the same way ibuprofen and naproxen do: it blocks enzymes called COX-1 and COX-2 that produce prostaglandins, the chemicals driving inflammation and pain signaling at the site of an injury. Because it targets the inflammation itself, ketorolac is especially useful for pain that involves tissue swelling, like a sprained ankle, a kidney stone, or surgical trauma. It does not produce any euphoria or sedation, and it has no abuse potential.

Tramadol takes a completely different route. It is a centrally acting analgesic, meaning it works inside the brain and spinal cord rather than at the injury site. It binds to mu-opioid receptors and also blocks the reuptake of serotonin and norepinephrine, two neurotransmitters involved in mood and pain modulation.1PubMed Central. Full Opioid Agonists and Tramadol: Pharmacological and Clinical Considerations That dual mechanism is unusual and has consequences for both effectiveness and safety. On one hand, the serotonin and norepinephrine effects may help with certain types of chronic pain, especially nerve-related pain, that pure anti-inflammatories cannot touch. On the other hand, those same effects open the door to interactions with antidepressants and other serotonin-affecting drugs.

Head-to-Head Pain Relief

Several randomized trials have directly compared ketorolac and tramadol across different types of acute pain, and the short version is that neither drug is categorically stronger than the other. Which one performs better often depends on the type of pain and the route of administration.

In an emergency department trial for musculoskeletal pain, a combination of tramadol with acetaminophen was about as effective as ketorolac with acetaminophen. The ketorolac group had a slight edge on pain-score improvement, but there was no meaningful difference in patient satisfaction or admission rates.2Hong Kong Journal of Emergency Medicine. A Randomised Control Trial Comparing the Efficacy of Tramadol and Paracetamol against Ketorolac and Paracetamol in the Management of Musculoskeletal Pain in the Emergency Department In orthopedic postoperative pain, intramuscular tramadol showed a somewhat more pronounced analgesic effect than intramuscular ketorolac, with a higher proportion of patients reporting relief at the one- and two-hour marks.3Current Therapeutic Research. Intramuscular tramadol versus ketorolac in patients with orthopedic and traumatologic postoperative pain: a comparative multicenter trial

For kidney stone pain, ketorolac pulled ahead in the first 15 minutes after injection, likely because inflammation plays a big role in renal colic and ketorolac tackles that directly. Overall efficacy beyond that early window was similar between the two drugs.4PubMed. Intramuscular ketorolac compared to subcutaneous tramadol in the initial emergency treatment of renal colic In a trial after abdominal hysterectomy, tramadol provided statistically better pain scores than ketorolac during the first 12 hours, though the difference narrowed after that point.

The takeaway across these trials is that both drugs are legitimate analgesics for acute pain, and the gap between them in any given study tends to be modest. The choice often comes down to what risks a patient can tolerate rather than which pill is “stronger.”

Postoperative Pain and Opioid-Sparing Strategies

Ketorolac has carved out a particularly strong reputation in surgical settings. It is widely used to reduce how much opioid medication a patient needs after an operation, which in turn reduces opioid-related side effects like respiratory depression, heavy sedation, and constipation.5Anesthesiology Clinics. Anesthesiology Clinics | Issue | ScienceDirect.com by Elsevier In a day-surgery trial for laparoscopic sterilization, patients given tramadol actually had less postoperative pain and needed rescue morphine less often than those given ketorolac.6PubMed. The analgesic efficacy of tramadol versus ketorolac in day-case laparoscopic sterilisation That result stands out because it is one of the clearer wins for tramadol in a surgical context, possibly because the laparoscopic procedure involves less tissue inflammation than, say, an open orthopedic operation.

For dental extractions, both drugs outperformed placebo. The rate of reported side effects was similar between them, though the specific side effects were different: the tramadol group reported more dizziness and giddiness, while the ketorolac group had a couple more cases of nausea.7PubMed Central. A double-blind, placebo-controlled randomized comparison of pre and postoperative administration of ketorolac and tramadol for dental extraction pain In maxillofacial surgery, the two drugs have been tested at standard intramuscular doses (ketorolac 30 mg, tramadol 100 mg) given at wound closure and repeated every eight hours.8PubMed Central. Tramadol versus ketorolac in the treatment of postoperative pain following maxillofacial surgery

In practice, many surgical teams use ketorolac as the default post-op painkiller for patients who can safely take NSAIDs, and add tramadol or other opioids only when the NSAID alone does not get pain under control. That layered approach keeps opioid exposure to a minimum.

Side Effects That Matter

The side-effect profiles of these two drugs barely overlap, which is why understanding them matters more than memorizing which one scored a point higher on a pain scale.

Ketorolac’s risks are the classic NSAID risks, but amplified because it is one of the most potent NSAIDs available. Gastrointestinal bleeding and perforation, impaired blood clotting, and kidney damage are all real concerns, and the risk climbs sharply with higher doses or treatment lasting longer than five days, or when given to older patients.9PubMed. Minimising the adverse effects of ketorolac That is why ketorolac is approved only for short-term use, typically no more than five days. It is not a drug you refill month after month. If you have a history of stomach ulcers, are on blood thinners, or have compromised kidney function, ketorolac is usually off the table.

Tramadol’s side-effect profile looks entirely different. The most common complaints are nausea, dizziness, drowsiness, sweating, vomiting, and dry mouth, occurring in roughly 2 to 6 percent of patients in perioperative studies.10PubMed. Tramadol: a review of its use in perioperative pain Those are nuisances for most people, but tramadol carries two rarer and far more serious risks: seizures and serotonin syndrome. These reactions are uncommon during normal use but become much more likely during overdose or when tramadol is combined with certain other medications, especially antidepressants.11PubMed Central. Tramadol: seizures, serotonin syndrome, and coadministered antidepressants

A large study of older nursing home residents found that taking tramadol together with antidepressants that inhibit a specific liver enzyme (CYP2D6) was associated with a higher seizure rate compared to taking tramadol with antidepressants that do not inhibit that enzyme.12PubMed Central. Risk of Seizure Associated With Concomitant Use of Tramadol and Antidepressants in Older Nursing Home Residents Common CYP2D6 inhibitors include fluoxetine (Prozac) and paroxetine (Paxil). If you take an antidepressant and are prescribed tramadol, this interaction is worth flagging with your prescriber.

The Dependence Question

Tramadol is a Schedule IV controlled substance in the United States, meaning federal regulators consider it to have real, though relatively low, abuse potential compared to drugs like oxycodone or morphine. Physical dependence can develop with daily use over weeks, and withdrawal symptoms, including anxiety, sweating, insomnia, and in some cases seizures, can occur if it is stopped abruptly. Ketorolac has no abuse potential whatsoever and is not a controlled substance. You will not develop cravings or withdrawal symptoms from it.

This distinction matters beyond the individual patient. In clinical settings that are trying to reduce overall opioid prescribing, ketorolac is appealing precisely because it provides strong acute pain relief without any of the addiction-related baggage. Tramadol was once considered a “safer opioid,” and while its abuse risk is genuinely lower than that of full-strength opioids, the years since it was reclassified as a controlled substance in 2014 reflect a consensus that it is not risk-free on this front.

Why Your Genetics Might Change How Well Tramadol Works

One quirk of tramadol is that your body has to metabolize it into an active form before it really starts working on opioid receptors. The liver enzyme responsible for that conversion is CYP2D6, and people vary enormously in how active that enzyme is. Roughly 5 to 10 percent of people of European descent are “poor metabolizers” who produce very little of the active metabolite, which means tramadol barely works for them. Research has confirmed that poor metabolizers of CYP2D6 have a lower response rate to tramadol for postoperative pain than people with normal enzyme activity.13PubMed. Impact of CYP2D6 genotype on postoperative tramadol analgesia CYP2D6 genetic variation also affects how quickly tramadol is cleared from the body and the likelihood of side effects.14PubMed. Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics

At the other extreme, “ultra-rapid metabolizers” convert tramadol into its active form much faster, which can lead to unexpectedly strong opioid effects, respiratory depression, and sedation at what should be a normal dose. This genetic lottery does not apply to ketorolac, because ketorolac does not need to be metabolically activated. What you swallow or get injected is what does the work. If you have ever tried tramadol and felt nothing, or tried it and felt far too sedated, CYP2D6 variation is a plausible explanation.

Who Should Avoid Which Drug

The two drugs map onto almost opposite sets of risk factors, which is actually helpful from a prescribing standpoint: if one is too risky for a given patient, the other often is not.

  • Kidney problems: Ketorolac is hard on the kidneys, especially in dehydrated patients or those with pre-existing renal impairment. Tramadol is the safer pick in that situation.
  • Bleeding risk: Ketorolac inhibits platelet function and can worsen bleeding. If you are on anticoagulants or have a clotting disorder, tramadol avoids that risk entirely.
  • History of seizures: Tramadol lowers the seizure threshold. If you have epilepsy or another seizure disorder, ketorolac is the safer choice.
  • Antidepressant use: SSRIs and SNRIs interact with tramadol’s serotonin reuptake inhibition, raising the risk of serotonin syndrome and seizures. Ketorolac has no such interaction.
  • Stomach ulcers or GI bleeding: Ketorolac is one of the worst choices in this scenario. Tramadol does not carry significant GI bleeding risk.
  • Substance use history: Tramadol has abuse potential and can trigger relapse. Ketorolac is a non-issue here.

For older adults, both drugs require caution but for different reasons. NSAIDs like ketorolac need dose adjustments and close monitoring of kidney function, blood pressure, and GI symptoms. Tramadol can be tolerated in older patients but carries risks of sedation, confusion, falls, and constipation, plus the seizure concern when combined with antidepressants.15PubMed. Pharmacotherapy for Spine-Related Pain in Older Adults The general principle for geriatric pain management is to start at the lowest effective dose and increase slowly.16PubMed. Postoperative analgesia in elderly patients

Ketorolac and Bone Healing

One concern that comes up frequently in orthopedic settings is whether ketorolac interferes with bone healing after a fracture or spinal fusion. Because NSAIDs suppress prostaglandins that play a role in bone repair, there has been worry that short-term ketorolac use after surgery could increase the risk of nonunion, where the bone fails to knit together properly.

The evidence on this is more reassuring than the worry suggests. Animal studies show a dose-dependent risk of delayed healing in rodents treated with high doses of ketorolac for four weeks or longer, but no evidence of harm with treatment lasting just seven days or at low doses. In human clinical data, some spine surgery studies have found a dose-dependent increase in nonunion risk after postoperative ketorolac, but other orthopedic specialties have not seen the same problem.17PubMed. Ketorolac and bone healing: a review of the basic science and clinical literature A large matched study of nearly 15,000 patients with long bone shaft fractures found no meaningful difference in nonunion rates between those who received postoperative ketorolac and those who did not, regardless of whether the fracture was in the tibia, femur, or humerus, and across all age groups.18PubMed Central. Postoperative Intravenous Ketorolac Does Not Affect Nonunion Risk in Surgically Treated Long Bone Shaft Fractures Short-term use for a few days after surgery appears safe for bone healing in most situations, though some spine surgeons remain cautious.

Tramadol does not carry any bone-healing concern, which gives it a theoretical edge in post-fracture or post-fusion pain management for patients whose surgeons want to avoid NSAIDs entirely.

Migraine and Other Specific Pain Scenarios

Both drugs show up in emergency treatment protocols for acute migraine, though they play different roles. NSAIDs, with ketorolac being the most frequently studied in the class, are generally well tolerated for migraine and may provide relief even when given later in an attack. Tramadol has been shown to be better than placebo for migraine pain, but opioids in general are considered a second-line or rescue option for headaches because of concerns about medication-overuse headache with repeated use.19PubMed Central. Rescue therapy for acute migraine, part 3: opioids, NSAIDs, steroids, and post-discharge medications In most emergency department migraine protocols, ketorolac is preferred over tramadol when NSAIDs are not contraindicated.

For dental pain after extractions or oral surgery, ketorolac taken by mouth before the procedure has been compared directly with intramuscular tramadol given at the same time.20PubMed Central. Comparison of the analgesic efficacy of oral ketorolac versus intramuscular tramadol after third molar surgery: A parallel, double-blind, randomized, placebo-controlled clinical trial The anti-inflammatory properties of ketorolac give it a natural advantage in dental scenarios, where tissue swelling is a major driver of pain. Tramadol is a reasonable alternative for patients who cannot take NSAIDs, but it would not typically be the first choice for an inflamed extraction site.

Routes and Duration of Use

Ketorolac can be given as a pill, an intramuscular injection, or an intravenous push. The injectable forms are what you will encounter in emergency rooms and post-anesthesia care units, and they work fast. But the strict time limit matters: ketorolac is approved for a maximum of five days of use in any form, because the risk of GI bleeding and kidney injury rises substantially beyond that window. It is not designed for chronic pain management.

Tramadol comes primarily as an oral tablet or capsule, in both immediate-release and extended-release formulations. It can also be given intramuscularly. Unlike ketorolac, tramadol can be prescribed for longer-term use, which makes it an option for ongoing pain conditions, though the risk of dependence grows with duration. Extended-release tramadol is sometimes used for chronic conditions like osteoarthritis or low back pain, though it has been losing favor as awareness of opioid risks has grown.

The practical upshot is that if you need a powerful, short-duration painkiller for an acute event — surgery, a kidney stone, an ER visit for a fracture — ketorolac is often the go-to. If you need something that can be taken for a longer stretch, tramadol is the one that can fill that role, with appropriate caution. The two drugs occupy different time horizons as much as they occupy different drug classes.